scholarly journals Faculty Opinions recommendation of Are there multiple cells of origin of Merkel cell carcinoma?

Author(s):  
Paul Nghiem
Oncogene ◽  
2018 ◽  
Vol 37 (11) ◽  
pp. 1409-1416 ◽  
Author(s):  
J. C. Sunshine ◽  
N. S. Jahchan ◽  
J. Sage ◽  
J. Choi

2019 ◽  
Vol 60 (4) ◽  
Author(s):  
Anes Yang ◽  
Carolina Cordoba ◽  
Karen Cheung ◽  
Joseph Konya

2012 ◽  
Vol 2012 ◽  
pp. 1-6 ◽  
Author(s):  
Thomas Tilling ◽  
Ingrid Moll

Merkel cell carcinoma (MCC), a highly aggressive skin tumour with increasing incidence, is associated with the newly discovered Merkel cell polyomavirus (MCPyV). Studies on MCC and MCPyV as well as other risk factors have significantly increased our knowledge of MCC pathogenesis, but the cells of origin, which could be important targets in future therapies, are still unknown. Merkel cells (MCs), the neuroendocrine cells of the skin, were believed to be at the origin of MCC due to their phenotypic similarities. However, for several reasons, for example, heterogeneous differentiation of MCCs and postmitotic character of MCs, it is not very likely that MCC develops from differentiated MCs. Skin stem cells, probably from the epidermal lineage, are more likely to be cells of origin in MCC. Future studies will have to address these questions more directly in order to identify the physiological cells which are transformed to MCC cells.


Cancers ◽  
2020 ◽  
Vol 12 (7) ◽  
pp. 1774 ◽  
Author(s):  
Valeria Pietropaolo ◽  
Carla Prezioso ◽  
Ugo Moens

Viruses are the cause of approximately 15% of all human cancers. Both RNA and DNA human tumor viruses have been identified, with Merkel cell polyomavirus being the most recent one to be linked to cancer. This virus is associated with about 80% of Merkel cell carcinomas, a rare, but aggressive cutaneous malignancy. Despite its name, the cells of origin of this tumor may not be Merkel cells. This review provides an update on the structure and life cycle, cell tropism and epidemiology of the virus and its oncogenic properties. Putative strategies to prevent viral infection or treat virus-positive Merkel cell carcinoma patients are discussed.


2018 ◽  
Vol 2018 ◽  
pp. 1-6
Author(s):  
Ajay Prakash ◽  
Alhossain A. Khalafallah

Hairy cell leukemia (HCL) and Merkel cell carcinoma (MCC) are two rare malignancies with distinct cells of origin. HCL is a lymphoid malignancy of mature B cells, and MCC derives from neuroendocrine cell origin. HCL has a favorable prognosis with most patients achieving long-term remission and potential cure. In contrast, MCC is an aggressive malignancy affecting the skin and can metastasize quickly with a dismal prognosis. Immunocompromised patients, such as those with AIDS, posttransplant, and the elderly, have higher incidences than the general population, suggesting a possible immune mechanism. We report a case where a patient presented with HCL and metastatic MCC synchronously. This is the first reported case of these two rare malignancies occurring concurrently at initial presentation and may represent a role of immunosuppression in the pathogenesis of MCC.


Sign in / Sign up

Export Citation Format

Share Document